Ipidacrine

	WikiDoc Resources for Ipidacrine
Articles
Most recent articles on Ipidacrine Most cited articles on Ipidacrine Review articles on Ipidacrine Articles on Ipidacrine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ipidacrine Images of Ipidacrine Photos of Ipidacrine Podcasts & MP3s on Ipidacrine Videos on Ipidacrine
Evidence Based Medicine
Cochrane Collaboration on Ipidacrine Bandolier on Ipidacrine TRIP on Ipidacrine
Clinical Trials
Ongoing Trials on Ipidacrine at Clinical Trials.gov Trial results on Ipidacrine Clinical Trials on Ipidacrine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ipidacrine NICE Guidance on Ipidacrine NHS PRODIGY Guidance FDA on Ipidacrine CDC on Ipidacrine
Books
Books on Ipidacrine
News
Ipidacrine in the news Be alerted to news on Ipidacrine News trends on Ipidacrine
Commentary
Blogs on Ipidacrine
Definitions
Definitions of Ipidacrine
Patient Resources / Community
Patient resources on Ipidacrine Discussion groups on Ipidacrine Patient Handouts on Ipidacrine Directions to Hospitals Treating Ipidacrine Risk calculators and risk factors for Ipidacrine
Healthcare Provider Resources
Symptoms of Ipidacrine Causes & Risk Factors for Ipidacrine Diagnostic studies for Ipidacrine Treatment of Ipidacrine
Continuing Medical Education (CME)
CME Programs on Ipidacrine
International
Ipidacrine en Espanol Ipidacrine en Francais
Business
Ipidacrine in the Marketplace Patents on Ipidacrine
Experimental / Informatics
List of terms related to Ipidacrine

Ipidacrine
Clinical data
Trade names	Neiromidin
Synonyms	Amiridine; NIK-247
ATC code	N06DA05 (WHO) ;
Legal status
Legal status	US: Unscheduled ;
Identifiers
	IUPAC name 2,3,5,6,7,8-Hexahydro-1H-cyclopenta[b]quinolin-9-amine;
PubChem CID	604519;
ChemSpider	525510;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C12H16N2
Molar mass	188.27 g/mol
3D model (JSmol)	Interactive image;
	SMILES C1CCc2c(c(c3c(n2)CCC3)N)C1;
	InChI InChI=1S/C12H16N2/c13-12-8-4-1-2-6-10(8)14-11-7-3-5-9(11)12/h1-7H2,(H2,13,14); Key:YLUSMKAJIQOXPV-UHFFFAOYSA-N;

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ipidacrine (Neiromidin) is a novel substance synthesized by the National Research Center for Biologically Active Compounds in the Russian Federation. This compound contains the structure of 4-aminopyridine and is structurally very similar to tacrine.^[1]

Ipidacrine is a reversible acetylcholinesterase inhibitor used in memory disorders of different origins.^[2]^[3]^[4]

Ipidacrine directly stimulates impulse transmission in the CNS and neuromuscular synapses by blocking membrane potassium channels. Neiromidin enhances not only choline, but also adrenaline, serotonin, histamine and oxytocin effects on smooth muscle.^[5]

References

↑ Kojima, Jun; Onodera, Kenji; Ozeki, Mitsuo; Nakayama, Kunio (1998). "Ipidacrine (NIK-247): A Review of Multiple Mechanisms as an Antidementia Agent". CNS Drug Reviews. 4 (3): 247. doi:10.1111/j.1527-3458.1998.tb00067.x.
↑ Damulin, IV; Stepkina, DA; Lokshina, AB (2011). "Neuromidin in mixed vascular and Alzheimer's dementia". Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoi promyshlennosti Rossiiskoi Federatsii, Vserossiiskoe obshchestvo nevrologov \i] Vserossiiskoe obshchestvo psikhiatrov. 111 (2): 40–3. PMID 21350422.
↑ Pustokhanova, LV; Morozova, EM (2011). "Cognitive disorders in the early rehabilitation period of ischemic stroke and possibilities of their treatment with neuromidin". Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoi promyshlennosti Rossiiskoi Federatsii, Vserossiiskoe obshchestvo nevrologov \i] Vserossiiskoe obshchestvo psikhiatrov. 111 (4 Pt 2): 23–7. PMID 23120773.
↑ Onodera, K; Kojima, J; Wachi, M (1998). "Ipidacrine (NIK-247), a novel antidementia, rapidly enters the brain and improves scopolamine-induced amnesia in rats during the Morris water maze task". Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology. 18 (2): 33–7. PMID 9656230.
↑ Neiromidin Product Information

Template:Anti-dementia drugs

[1] Kojima, Jun; Onodera, Kenji; Ozeki, Mitsuo; Nakayama, Kunio (1998). "Ipidacrine (NIK-247): A Review of Multiple Mechanisms as an Antidementia Agent". CNS Drug Reviews. 4 (3): 247. doi:10.1111/j.1527-3458.1998.tb00067.x.

[2] Damulin, IV; Stepkina, DA; Lokshina, AB (2011). "Neuromidin in mixed vascular and Alzheimer's dementia". Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoi promyshlennosti Rossiiskoi Federatsii, Vserossiiskoe obshchestvo nevrologov \i] Vserossiiskoe obshchestvo psikhiatrov. 111 (2): 40–3. PMID 21350422.

[3] Pustokhanova, LV; Morozova, EM (2011). "Cognitive disorders in the early rehabilitation period of ischemic stroke and possibilities of their treatment with neuromidin". Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoi promyshlennosti Rossiiskoi Federatsii, Vserossiiskoe obshchestvo nevrologov \i] Vserossiiskoe obshchestvo psikhiatrov. 111 (4 Pt 2): 23–7. PMID 23120773.

[4] Onodera, K; Kojima, J; Wachi, M (1998). "Ipidacrine (NIK-247), a novel antidementia, rapidly enters the brain and improves scopolamine-induced amnesia in rats during the Morris water maze task". Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology. 18 (2): 33–7. PMID 9656230.

[5] Neiromidin Product Information

[1]

[2]

[3]

[4]

[5]

Ipidacrine

Overview

References

Navigation menu